Aquila Investment Management’s DexCom DXCM Stock Holding History

Aquila Investment Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$2.82M	Buy	42,000 +14,000	+50%	+$1.15M	3.13%	9
2024 Q2	$3.17M	Hold	28,000	–	–	2.98%	5
2024 Q1	$3.88M	Hold	28,000	–	–	3.31%	5
2023 Q4	$3.47M	Buy	+28,000	New	+$2.86M	3.01%	4
2023 Q3	–	Sell	-5,000	Closed	-$643K	–	87
2023 Q2	$643K	Buy	+5,000	New	+$605K	0.53%	75
2023 Q1	–	Sell	-18,000	Closed	-$2.04M	–	93
2022 Q4	$2.04M	Buy	18,000 +4,000	+29%	+$439K	1.58%	16
2022 Q3	$1.13M	Hold	14,000	–	–	0.84%	55
2022 Q2	$1.04M	Buy	14,000 +10,000	+250%	+$913K	0.74%	62
2022 Q1	$512K	Buy	+4,000	New	+$438K	0.29%	83

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Aquila Investment Management's DXCM Position: Q3 2024 in Review

Aquila Investment Management increased its DexCom (DXCM) stake by 50% in Q3 2024, buying an estimated $1.15M and bringing the position to 42,000 shares worth $2.82M. The position accounts for 3.13% of the portfolio, ranked #9.

Aquila Investment Management first reported a position in DXCM in Q1 2022 and has held it in 9 quarters since. The position peaked at $3.88M in Q1 2024. 890 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

Aquila Investment Management held 42,000 shares of DexCom worth $2.82M as of Q3 2024.
Aquila Investment Management bought 14,000 DexCom shares in Q3 2024, an estimated $1.15M.
DexCom made up 3.13% of Aquila Investment Management's portfolio in Q3 2024, its #9 holding.
Aquila Investment Management first reported a position in DexCom in Q1 2022 and has held it in 9 quarters since.
Aquila Investment Management's DexCom position peaked at $3.88M in Q1 2024.
890 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on Aquila Investment Management's 13F filing for Q3 2024, filed 22 Oct 2024.